[Translation] A randomized, double-blind, placebo-controlled Phase I clinical study to evaluate the safety and tolerability of XLH01 tablets in healthy subjects
主要目的:
1.评价在健康受试者中单次、多次口服XLH01片后的安全性、耐受性;
2.评价食物(高脂高热量餐)对XLH01片药代动力学的影响。
次要目的:
1.评价在健康受试者中单次、多次口服XLH01片后的药代动力学特征;
2.评价健康受试者在餐后状态下(高脂高热量餐)口服XLH01片的安全性;
3.评价在健康受试者中多次口服XLH01片后的初步药效动力学特征。
[Translation] Main objectives:
1. To evaluate the safety and tolerability of XLH01 tablets after single and multiple oral administration in healthy subjects;
2. To evaluate the effect of food (high-fat and high-calorie meal) on the pharmacokinetics of XLH01 tablets.
Secondary objectives:
1. To evaluate the pharmacokinetic characteristics of XLH01 tablets after single and multiple oral administration in healthy subjects;
2. To evaluate the safety of oral administration of XLH01 tablets in healthy subjects in the postprandial state (high-fat and high-calorie meal);
3. To evaluate the preliminary pharmacodynamic characteristics of XLH01 tablets after multiple oral administration in healthy subjects.